SLT therapy is used to treat glaucoma, the leading cause of blindness in North America and Europe, and the second leading cause worldwide. Glaucoma is most often associated with an increase of pressure inside the eye, which, over time, can cause damage to some of the sensitive structures that receive and transmit images in the back of the eye, ultimately resulting in irreversible loss of vision.

SLT photoregeneration is a gentle, non-invasive and repeatable laser treatment which stimulates a natural healing response in the body to manage intraocular pressure, promoting cellular regeneration without the burn and scar tissue associated with other laser procedures

SLT is an effective primary treatment for open-angle glaucoma, and is especially suited to patients who cannot tolerate or are unable to self-administer glaucoma medications. It is also a flexible treatment option, given that it can be repeated, if necessary, in accordance with varied patient responses, and can also be used in conjunction with traditional drug therapy. There are no major risks or complications and side effects are minimal.

Good candidates for SLT include primary-open angle, normal tension pseudoexfoliation, or pigmentary glaucoma patients who:

• Wish to use SLT as a primary glaucoma treatment
• Find it challenging to take glaucoma medications due to time or financial constraints, non-compliance and quality-of-life issues
• Are currently undergoing drug therapy and need to further reduce IOP without adding drugs
• Wish to keep the number of drugs to a minimum
• Do not tolerate drugs due to their adverse effects
• Experience loss of the pressure-lowering effects of drug therapy
• Have had Argon Laser Trabeculoplasty that has failed